Projected Earnings Date: 2024-02-12    (Delayed quote data   )
Last
 
Change
 ⇓ 0.00   (%)
Volume
  0
Open
 
High
 
Low
 
8EMA (Daily)
 0.00
40EMA (Daily)
 
50EMA (Daily)
 
STO (Daily)
 
MACD Hist (Daily)
 
8EMA (Weekly)
 1.751
40EMA (Weekly)
 5.89
50EMA (Weekly)
 8.25
STO (Weekly)
 6.071
MACD Hist (Weekly)
 0.227
HTG Molecular Diagnostics Inc is a commercial stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological sample, in liquid or solid forms. Its products include instruments, consumables and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com